T1 Mapping MOLLI 5(3)3 Acquisition Scheme Yields High Accuracy in 1.5 T Cardiac Magnetic Resonance.
MOLLI
T1 mapping
accuracy
cardiac magnetic resonance imaging
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
08 Nov 2022
08 Nov 2022
Historique:
received:
26
09
2022
revised:
01
11
2022
accepted:
03
11
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Objectives: To systematically compare two modified Look-Locker inversion recovery (MOLLI) T1 mapping sequences and their impact on (1) myocardial T1 values native, (2) post-contrast and (3) extracellular volume (ECV). Methods: 200 patients were prospectively included for 1.5 T CMR for work-up of ischemic or non-ischemic cardiomyopathies. To determine native and post-contrast T1 for ECV calculation, two different T1 mapping MOLLI acquisition schemes, 5(3)3 (designed for native scans with long T1) and 4(1)3(1)2 (designed for post-contrast scans with short T1), were acquired in identical mid-ventricular short-axis slices. Both schemes were acquired in native and post-contrast scans. Results: Datasets from 163 patients were evaluated (age 55 ± 17 years; 38% female). Myocardial T1 native for 5(3)3 was 1017 ± 42 ms vs. 956 ± 40 ms for 4(1)3(1)2, with mean intraindividual difference −61 ms (p < 0.0001). Post-contrast myocardial T1 in patients was similar for both acquisition schemes, with 494 ± 48 ms for 5(3)3 and 490 ± 45 ms for 4(1)3(1)2 and mean intraindividual difference −4 ms. Myocardial ECV for 5(3)3 was 27.6 ± 4% vs. 27 ± 4% for 4(1)3(1)2, with mean difference −0.6 percentage points (p < 0.0001). Conclusions: The T1 MOLLI 5(3)3 acquisition scheme provides a reliable estimation of myocardial T1 for the clinically relevant range of long and short T1 values native and post-contrast. In contrast, the T1 MOLLI 4(1)3(1)2 acquisition scheme may only be used for post-contrast scans according to its designed purpose.
Identifiants
pubmed: 36359572
pii: diagnostics12112729
doi: 10.3390/diagnostics12112729
pmc: PMC9689660
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 374031971 - TRR 240
Références
J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75
pubmed: 28992817
F1000Res. 2016 Sep 07;5:
pubmed: 27635240
MAGMA. 2018 Feb;31(1):143-163
pubmed: 28608328
J Cardiovasc Magn Reson. 2017 Jan 6;19(1):6
pubmed: 28077133
Front Cardiovasc Med. 2022 Sep 30;9:989376
pubmed: 36247463
J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89
pubmed: 27899132
J Cardiovasc Magn Reson. 2013 Jun 21;15:56
pubmed: 23800276
BMC Med Imaging. 2019 Aug 1;19(1):59
pubmed: 31370821
J Magn Reson Imaging. 2016 Jul;44(1):186-93
pubmed: 26717865
J Clin Med. 2022 Aug 28;11(17):
pubmed: 36078976
Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):768-776
pubmed: 29237044
Radiology. 2014 Sep;272(3):683-9
pubmed: 24702727
JACC Cardiovasc Imaging. 2020 May;13(5):1221-1234
pubmed: 31542534
J Cardiovasc Magn Reson. 2013 Oct 14;15:92
pubmed: 24124732
Eur J Radiol. 2018 Dec;109:235-247
pubmed: 30539759
J Magn Reson Imaging. 2020 Nov;52(5):1340-1351
pubmed: 31837078
Rofo. 2015 Sep;187(9):760-70
pubmed: 26098250
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):55-57
pubmed: 31202764
J Clin Med. 2022 Aug 30;11(17):
pubmed: 36079039
Rofo. 2020 Mar;192(3):246-256
pubmed: 31747705